Limoneira Company (LMNR) Q3 2024 Earnings Call Transcript Summary
Limoneira Company (LMNR) Q3 2024 Earnings Call Transcript Summary
Net income for Q3 was $6.5 million, compared to a net loss of $1.3 million in the previous year, with earnings per share at $0.35.The following is a summary of the Limoneira Company (LMNR) Q3 2024 Earnings Call Transcript:
以下是利莫內拉公司（LMNR）2024年第三季度業績電話會議記錄摘要：
Financial Performance:
財務業績：
Limoneira reported a 21% increase in net revenue for Q3, totaling $63.3 million.
Adjusted EBITDA for Q3 was $13.8 million, reflecting significant growth from $2.8 million in the same period last year.
Net income for Q3 was $6.5 million, compared to a net loss of $1.3 million in the previous year, with earnings per share at $0.35.
Limoneira報告稱，第三季度淨收入增長了21％，總額爲6,330萬美元。
第三季度調整後的息稅折舊攤銷前利潤爲1,380萬美元，較去年同期的280萬美元大幅增長。
第三季度的淨收入爲650萬美元，而去年同期的淨虧損爲130萬美元，每股收益爲0.35美元。
Business Progress:
業務進展：
Expanded avocado production significantly, raising volume guidance by over 50%, with expectations for continued robust demand.
Completed the sellout of Phase 2 in the Harvest at Limoneira project, with ongoing development to further increase residential unit numbers.
Reduced long-term debt by 33% and shifted towards an asset lighter business model, enhancing financial stability and shareholder value.
大幅擴大了鱷梨的產量，將產量預期提高了50％以上，預計需求將持續強勁。
Limoneira項目已完成第二階段的售罄，目前正在進行開發以進一步增加住宅單元的數量。
將長期債務減少了33％，轉向資產較輕的商業模式，從而提高了財務穩定性和股東價值。
Opportunities:
機會：
Strong performance in avocado and lemon segments, with increased sales volumes and pricing, pointing towards promising market conditions and consumer demand.
The approval to increase residential units in the Harvest project represents potential real estate development growth.
鱷梨和檸檬細分市場的強勁表現，銷量和價格的增加，表明市場狀況和消費者需求前景樂觀。
在Harvest項目中增加住宅單元的批准代表了房地產開發的潛在增長。
Risks:
風險：
Seasonal nature of business influences quarterly performance fluctuations. Uncertainty surrounds the strategic review of business operations and its potential impacts.
業務的季節性質會影響季度業績波動。不確定性圍繞着業務運營的戰略審查及其潛在影響。
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。
